Skyhawk Therapeutics Revenue and Competitors

Boston, MA USA

Location

$181.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Skyhawk Therapeutics's estimated annual revenue is currently $13.5M per year.(i)
  • Skyhawk Therapeutics's estimated revenue per employee is $155,000
  • Skyhawk Therapeutics's total funding is $181.2M.

Employee Data

  • Skyhawk Therapeutics has 87 Employees.(i)
  • Skyhawk Therapeutics grew their employee count by -94% last year.

Skyhawk Therapeutics's People

NameTitleEmail/Phone
1
Co-founder & Executive ChairmanReveal Email/Phone
2
SVP ChemistryReveal Email/Phone
3
Head Business DevelopmentReveal Email/Phone
4
VP LegalReveal Email/Phone
5
SVP, Discovery BiologyReveal Email/Phone
6
ControllerReveal Email/Phone
7
Director, Discovery BiologyReveal Email/Phone
8
Director ChemistryReveal Email/Phone
9
Associate Director, BioinformaticsReveal Email/Phone
10
Senior Director, BioinformaticsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Skyhawk Therapeutics?

Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression. Our founders are leading experts in small molecule therapeutics development for RNA-based disease. Our first drug candidates are targeted towards cancers and neurological conditions. The company is based in Waltham, Massachusetts. For more information, please visit: www.skyhawktx.com.

keywords:N/A

$181.2M

Total Funding

87

Number of Employees

$13.5M

Revenue (est)

-94%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Skyhawk Therapeutics News

2022-03-30 - RNA-Targeted Small Molecules Market Size 2022, CAGR Value, Top Key Players, Competitive Landscape and Recent

... H3 Biomedicine Inc., Novartis AG, PTC Therapeutics, Ribometrix, SERVIER LABORATORIES, Skyhawk Therapeutics, , Other Market Participants.

2018-06-26 - Skyhawk Therapeutics Raises $40M in Equity Funding Round

Skyhawk Therapeutics, Inc., a Cambridge, Mass.-based drug development company, closed a new $40m equity investment round alongside its recently announced $60m strategic collaboration. This brings total new capital into the company to over $100m. Participants in the all-common stock equity round ...

2018-06-26 - Skyhawk Therapeutics Announces $40 Million Equity Investment Round

Skyhawk Therapeutics, Inc., today announced the closing of a new $40 million equity investment round alongside its recently announced $60 million strategic collaboration, bringing total new capital into the company to over $100 million. Proceeds will be used for development of Skyhawk's innovati ...

2018-01-24 - Skyhawk Therapeutics Raises $8M in Seed Financing

Skyhawk Therapeutics, Inc., a Waltham, Mass.-based company focused on the discovery and development of small molecule therapeutics that correct RNA expression, closed $8m seed funding round. The round was led by major family and biotech investors, including Tim Disney, the Duke of Bedford, Alex ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$19.1M870%N/A
#2
$16.1M87-13%$233M
#3
$20M8838%N/A
#4
$8.8M88-2%N/A
#5
$15.1M89-2%N/A